EWTX
Price
$15.06
Change
-$0.26 (-1.70%)
Updated
Oct 17 closing price
Capitalization
1.59B
19 days until earnings call
NBTX
Price
$25.60
Change
-$0.97 (-3.65%)
Updated
Oct 17 closing price
Capitalization
1.33B
31 days until earnings call
Interact to see
Advertisement

EWTX vs NBTX

Header iconEWTX vs NBTX Comparison
Open Charts EWTX vs NBTXBanner chart's image
Edgewise Therapeutics
Price$15.06
Change-$0.26 (-1.70%)
Volume$679.1K
Capitalization1.59B
Nanobiotix SA
Price$25.60
Change-$0.97 (-3.65%)
Volume$81.15K
Capitalization1.33B
EWTX vs NBTX Comparison Chart in %
EWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EWTX vs. NBTX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EWTX is a Hold and NBTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (EWTX: $15.06 vs. NBTX: $25.60)
Brand notoriety: EWTX and NBTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EWTX: 78% vs. NBTX: 99%
Market capitalization -- EWTX: $1.59B vs. NBTX: $1.33B
EWTX [@Biotechnology] is valued at $1.59B. NBTX’s [@Biotechnology] market capitalization is $1.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EWTX’s FA Score shows that 1 FA rating(s) are green whileNBTX’s FA Score has 0 green FA rating(s).

  • EWTX’s FA Score: 1 green, 4 red.
  • NBTX’s FA Score: 0 green, 5 red.
According to our system of comparison, EWTX is a better buy in the long-term than NBTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EWTX’s TA Score shows that 4 TA indicator(s) are bullish while NBTX’s TA Score has 3 bullish TA indicator(s).

  • EWTX’s TA Score: 4 bullish, 4 bearish.
  • NBTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, EWTX is a better buy in the short-term than NBTX.

Price Growth

EWTX (@Biotechnology) experienced а -0.33% price change this week, while NBTX (@Biotechnology) price change was +8.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

EWTX is expected to report earnings on Nov 06, 2025.

NBTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EWTX($1.59B) has a higher market cap than NBTX($1.33B). NBTX YTD gains are higher at: 791.986 vs. EWTX (-43.596).
EWTXNBTXEWTX / NBTX
Capitalization1.59B1.33B119%
EBITDA-172.19MN/A-
Gain YTD-43.596791.986-6%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash594MN/A-
Total Debt4.37MN/A-
TECHNICAL ANALYSIS
Technical Analysis
EWTXNBTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
EWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NAWCX47.030.27
+0.58%
Voya Global High Dividend Low Vol C
STRAX34.600.13
+0.38%
Sterling Capital Behav Lg Cp Val Eq R6
HILCX23.340.02
+0.09%
Hartford International Value C
LSSNX30.450.01
+0.03%
Loomis Sayles Small Cap Growth N
TRPWX23.28-0.07
-0.30%
Nuveen Quant Mid Cap Growth R6

EWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EWTX has been loosely correlated with CGON. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if EWTX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EWTX
1D Price
Change %
EWTX100%
-1.70%
CGON - EWTX
42%
Loosely correlated
-0.93%
SYRE - EWTX
42%
Loosely correlated
+1.03%
IMTX - EWTX
39%
Loosely correlated
-3.24%
VRDN - EWTX
38%
Loosely correlated
+5.22%
CRNX - EWTX
38%
Loosely correlated
-1.75%
More

NBTX and

Correlation & Price change

A.I.dvisor tells us that NBTX and PBYI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBTX and PBYI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBTX
1D Price
Change %
NBTX100%
-3.65%
PBYI - NBTX
28%
Poorly correlated
+1.11%
GLMD - NBTX
26%
Poorly correlated
-2.84%
EWTX - NBTX
26%
Poorly correlated
-1.70%
CRMD - NBTX
25%
Poorly correlated
+0.99%
VALN - NBTX
25%
Poorly correlated
-1.86%
More